Search
for
Sort by
Research 331–360 of 1000+
- Actinic Keratosis: Risk Factors, Clinical, Diagnosis and Therapeutics Aspects. Part I
- Abstract PS1-04-01: Misguided Relief: Prevalence and Patterns of Symptom Management Misinformation for Breast Cancer on Instagram
- Chinese Herbal Medicine for Reducing Chemotherapy-Associated Side-Effects in Breast Cancer Patients: A Systematic Review and Meta-Analysis
- Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022
- Chemotherapy-Induced Alopecia in Breast Cancer Patients: Treatment-Specific Incidence and Risk of Persistent Hair Loss
- Gender-Affirming Hormone Therapy for Transgender Men
- Alopecia in a premenopausal breast cancer woman treated with letrozole and triptorelin
- Open-Label, Randomized, Multicenter, Phase III Study Comparing Oral Paclitaxel Plus Encequidar Versus Intravenous Paclitaxel in Patients With Metastatic Breast Cancer
- Finasteride Use and Risk of Male Breast Cancer: A Case–Control Study Using Individual-Level Registry Data from Denmark, Finland, and Sweden
- Causal associations between plasma proteins and prostate cancer: a Proteome-Wide Mendelian Randomization
- Therapeutic Androgen Receptor Ligands
- 5-Alpha-Reductase Inhibitors and Combination Therapy
- Targeting Wnt Signaling for Gastrointestinal Cancer Therapy: Present and Evolving Views
- The Chinese herb Xiaoaiping protects against breast cancer chemotherapy-induced alopecia and other side effects: a randomized controlled trial
- Anti-invasive effects of minoxidil on human breast cancer cells: combination with ranolazine
- Advances of Microneedles for Cancer Diagnosis and Therapy
- Hair safe study: Effects of scalp cooling on hair preservation and hair regrowth in breast cancer patients receiving chemotherapy - A prospective interventional study
- Correlation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic breast carcinoma
- Efficacy and safety of a novel anti‐HER2 therapeutic antibody RC48 in patients with HER2‐overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single‐arm phase II study
- Targeting the Hippo/YAP/TAZ signalling pathway: Novel opportunities for therapeutic interventions into skin cancers
- Canadian Expert Recommendations on Safety Overview and Toxicity Management Strategies for Sacituzumab Govitecan Based on Use in Metastatic Triple-Negative Breast Cancer
- Chemotherapy-related adverse effects with anthracycline and taxane-containing regimens in patients with localized Breast cancer: a descriptive study
- Exploring the therapeutic potential of Selaginella doederleinii extract for cervical cancer treatment through network pharmacology and in vitro studies
- Clinicopathologic Characteristics and Response to Treatment of Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors
- The Impact of Chemotherapy on the Nutritional Status of Breast Cancer Patients
- Review of Drug Repositioning in Cancer Therapeutics
- Optimizing hair care products and practices for Black patients with breast cancer: One size does not fit all
- Neoadjuvant therapy with Disitamab vedotin in treating muscle-invasive bladder cancer: A case report
- Safety First: A Comprehensive Review of Nutritional Supplements for Hair Loss in Breast Cancer Patients
- Mucocutaneous Side Effects of Antineoplastic Drugs Used in Cancer Therapy in Erbil